Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by ABBVIE ENDOCRINE INC
FDA Drug Application 020708 by ABBVIE ENDOCRINE INC
Application Number
020708
Application Type
New Drug Application
Sponsor Applicant
ABBVIE ENDOCRINE INC
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New formulation
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
3/7/1997
N
6450
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020708_lupron_toc.cfm
8/8/2003
AP
0
3/7/1997
N
31116
000
http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
12/20/2011
AP
0
9/4/1997
SLR
AP
0
12/23/1997
SCS
AP
0
4/9/1998
SLR
2744
003
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20011-s014_Lupron.cfm
8/6/2001
AP
0
4/9/1998
SLR
4802
003
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20011-S014_LUPRON_APPROV.PDF
4/9/1998
AP
0
7/29/1998
SCS
AP
0
2/11/1999
SE8
855
005
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20708s5.cfm
6/22/1999
AP
0
2/11/1999
SE8
4803
005
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20708s5_appltr.pdf
2/11/1999
AP
0
8/13/1999
SCM
17202
006
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/020708_S006_Lupron Depot_APPROVAL PACKAGE.pdf
7/9/2007
AP
0
5/11/2000
SCS
AP
0
5/12/2000
SCS
AP
0
1/24/2001
SCS
AP
0
3/1/2001
SLR
AP
0
9/21/2001
SE1
2745
011
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/20708s11ltr.pdf
9/21/2001
AP
0
9/21/2001
SE1
2746
011
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-708S011_Lupron.cfm
11/14/2001
AP
0
9/21/2001
SE1
4800
011
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-708S011_Lupron_prntlbl.pdf
9/21/2001
AP
0
7/23/2001
SCS
AP
0
11/14/2001
SLR
AP
0
5/23/2002
SCS
AP
0
1/15/2004
SLR
7580
015
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/19943slr018,20011slr025,20708slr015ltr.pdf
1/22/2004
AP
0
9/20/2002
SCS
AP
0
1/12/2004
SLR
7535
018
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/19732s026,19943s021,20011s028,20517s016,20708s018ltr.pdf
1/14/2004
AP
0
9/15/2005
SCS
12945
020
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/0197322729190103119943222420517181920708202120011tr.pdf
10/20/2005
AP
0
9/15/2005
SCS
17201
020
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/020708_S020_Lupron Depot_APPROVAL PACKAGE.pdf
7/9/2007
AP
0
9/15/2005
SLR
12946
021
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/0197322729190103119943222420517181920708202120011tr.pdf
10/20/2005
AP
0
9/15/2005
SLR
17200
021
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/020708_S021_Lupron Depot_APPROVAL PACKAGE.pdf
7/9/2007
AP
0
10/31/2007
SLR
18376
026
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/019943s026, 020011s033, 020708s026ltr.pdf
11/8/2007
AP
0
6/2/2009
SLR
22688
029
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020708s029lbl.pdf
6/4/2009
AP
0
6/2/2009
SLR
22715
029
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020708s029ltr.pdf
6/8/2009
AP
0
10/29/2010
SLR
26838
030
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020708s030lbl.pdf
10/29/2010
AP
0
10/29/2010
SLR
26851
030
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020708s030ltr.pdf
11/2/2010
AP
0
3/28/2012
SLR
32264
031
http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019943s031,020011s038,020708s031lbl.pdf
3/28/2012
AP
0
3/28/2012
SLR
32319
031
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020708s031,019943s031,020011s038ltr.pdf
4/2/2012
AP
0
6/14/2011
SLR
29164
032
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020708s032ltr.pdf
6/16/2011
AP
0
6/14/2011
SLR
29180
032
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020708s032lbl.pdf
6/16/2011
AP
0
1/23/2012
SLR
31491
033
http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020708s033lbl.pdf
1/23/2012
AP
0
1/23/2012
SLR
31513
033
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020708s033ltr.pdf
1/25/2012
AP
0
10/30/2013
SLR
37633
034
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020708Orig1s034,019943Orig1s034,020011Orig1s041,203696Orig1s001ltr.pdf
10/31/2013
AP
0
10/30/2013
SLR
37698
034
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020708s034lbl.pdf
11/5/2013
Back to FDA Applications sponsored by ABBVIE ENDOCRINE INC